Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Antimicrob Agents Chemother ; 59(9): 5697-704, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26149989

RESUMEN

Previously, we demonstrated that a single prophylactic dose of SR-2P, a novel dual-component microbicide gel comprising acyclovir and tenofovir, led to a modest increase in mouse survival following a lethal challenge of herpes simplex virus 2 (HSV-2). Here, we show that a dose of SR-2P administered 24 h prior to infection provides some protection against the virus, but to a lesser degree than SR-2P administered either once a day for 2 days or 1 h prior to infection. None of the prophylactic doses blocked infection by the virus, and all resulted in 80 to 100% lethality. However, given that a prophylactic dose still provided a significant reduction in overall clinical score, reduced rate of body weight loss, and increased median survival of the mice, we examined whether a repetitive dose regimen (postinfection) in addition to the prophylactic dose could prevent death and reduce the levels of virus in mice. Nearly all (9 of 10 in each group) of the mice that received SR-2P for 2 days prior to infection or that received SR-2P 1 h prior to infection and were administered SR-2P once a day for 10 days after infection showed no clinical symptoms of infection and no viral loads in vaginal swabs and survived for 28 days postinfection. Conversely, mice receiving no treatment or an identical vehicle treatment demonstrated advanced clinical signs and did not survive past day 9 postinfection. We conclude that SR-2P is an effective anti-HSV-2 agent in mice.


Asunto(s)
Antivirales/uso terapéutico , Simplexvirus/efectos de los fármacos , Simplexvirus/patogenicidad , Cremas, Espumas y Geles Vaginales/administración & dosificación , Animales , Antivirales/administración & dosificación , Chlorocebus aethiops , Femenino , Herpes Simple/prevención & control , Ratones , Ratones Endogámicos BALB C , Células Vero
2.
Infect Immun ; 74(7): 4375-8, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16790815

RESUMEN

Helicobacter pylori BabA is the ABO blood group antigen binding adhesin, which has a closely related paralogue (BabB) whose function is unknown. PCR and DNA sequence analysis showed extensive genotypic diversity in babA and babB across different strains, as well as within a strain colonizing an individual patient. We hypothesize that diverse profiles of babA and babB reflect selective pressures for adhesion, which may differ across different hosts and within an individual over time.


Asunto(s)
Adhesinas Bacterianas/genética , Proteínas de la Membrana Bacteriana Externa/genética , Helicobacter pylori/genética , Helicobacter pylori/aislamiento & purificación , Adhesinas Bacterianas/biosíntesis , Adhesinas Bacterianas/fisiología , Adhesión Bacteriana/genética , Proteínas de la Membrana Bacteriana Externa/biosíntesis , Proteínas de la Membrana Bacteriana Externa/fisiología , Perfilación de la Expresión Génica , Variación Genética , Genotipo , Humanos , Datos de Secuencia Molecular
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda